Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort

INTRODUCTION: Several clinical studies have reported the efficacy of favipiravir in reducing viral load and shortening the duration of symptoms. However, the viability of SARS-CoV-2 in the context of favipiravir therapy and the potential for resistance development is unclear. METHODS: We sequenced S...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Masahiro, Imai, Takumi, Sakurai, Aki, Komoto, Satoshi, Ide, Tomihiko, Lim, Chang Kweng, Shintani, Ayumi, Doi, Yohei, Murata, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196299/
https://www.ncbi.nlm.nih.gov/pubmed/34176716
http://dx.doi.org/10.1016/j.jiac.2021.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196299/
https://www.ncbi.nlm.nih.gov/pubmed/34176716
http://dx.doi.org/10.1016/j.jiac.2021.06.010

Ejemplares similares